Higenamine — Hermetica Encyclopedia
Named Bioactive Compounds · Compound

Higenamine

Provisional Moderate Scorecompound

Hermetica Superfood Encyclopedia

Evidence review status: unreviewed

Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.

Review flags: AWAITING_SEMANTIC_VALIDATION

Provisional Summary

Higenamine is a benzylisoquinoline alkaloid derived from plants such as Aconitum japonicum and Nandina domestica that acts primarily as a beta-2 adrenergic receptor agonist. It stimulates adrenergic signaling pathways to produce cardiotonic and bronchodilatory effects, and is investigated as a stimulant in pre-workout formulations.

Screened PMID Records
Reported Benefits
Pending
Synergy Review
At a Glance
CategoryNamed Bioactive Compounds
GroupCompound
Public Score StatusProvisional Moderate
Primary Keywordhigenamine supplement
Higenamine close-up macro showing natural texture and detail — rich in bronchodilator, cardiostimulant, antioxidant
Higenamine — botanical close-up

Origin & History

Higenamine growing in natural environment — cultivated since 1976
Natural habitat

Higenamine (norcoclaurine) is a naturally occurring benzylisoquinoline alkaloid found in various plants including Aconitum carmichaelii roots, Nelumbo nucifera (lotus) leaves and seeds, and Nandina domestica fruit. First isolated in 1976 from Aconitum japonicum roots, it can be extracted from these plants or synthesized, with concentrations varying from 0.258-0.304 μg/g in Aconitum roots to 9.67-1183.8 μg/kg in lotus leaves and seeds.

In Chinese and Japanese folk medicine, Aconitum roots containing higenamine (as Baifupian/Heishunpian decoctions) have been traditionally used to treat fever, collapse, pain, gastroenteritis, diarrhea, edema, bronchial asthma, and tumors. The compound was first isolated and identified as the cardiotonic agent in 1976.Traditional Medicine

Research Narrative (Provisional)

The research dossier reveals a notable absence of human clinical trials, RCTs, or meta-analyses for higenamine. No PubMed PMIDs for controlled human studies are available, with evidence limited to plant detection studies and traditional use documentation.

Preparation & Dosage

Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.

Nutritional Profile

Higenamine (also known as norcoclaurine) is a benzylisoquinoline alkaloid, not a conventional nutrient — it contains no meaningful macronutrients, vitamins, minerals, or fiber. As a bioactive compound, it is found in trace concentrations across several plant sources: lotus seed embryos (Nelumbo nucifera) contain approximately 0.3–1.2 mg/g dry weight, Aconitum japonicum roots contain variable alkaloid fractions with higenamine as a minor constituent, and Nandina domestica fruits contain detectable but unquantified amounts. Bioavailability is reported to be rapid but short-lived — oral absorption occurs within 15–30 minutes in animal models, with a short half-life (~1–2 hours) due to catechol-O-methyltransferase (COMT)-mediated metabolism. As a β1/β2 adrenergic receptor agonist and potential norepinephrine reuptake inhibitor, its pharmacological activity is relevant at microgram-to-milligram doses (estimated active range: 5–20 mg in human supplementation contexts, though no formal clinical dosing has been established). It has no caloric value and no established Dietary Reference Intake.

Reported Mechanism (Provisional)

Mechanism of Action

Higenamine binds to beta-1 and beta-2 adrenergic receptors, activating adenylyl cyclase via Gs protein coupling and elevating intracellular cyclic AMP (cAMP), which drives positive chronotropic and inotropic cardiac responses. Its beta-2 agonism also relaxes bronchial smooth muscle by phosphorylating myosin light-chain kinase through PKA activation. Additionally, higenamine inhibits platelet aggregation by suppressing thromboxane A2 synthesis and may weakly inhibit acetylcholinesterase, contributing to its reported antitussive effects.

Clinical Narrative (Provisional)

Human clinical data on higenamine is extremely limited; most mechanistic evidence derives from in vitro cell studies and animal models using isolated cardiac and smooth muscle tissue. A small pharmacokinetic study in healthy volunteers (n=8) published in 2017 demonstrated rapid oral absorption with a Cmax reached within 10 minutes and a short half-life of approximately 8 minutes, indicating poor bioavailability concerns for supplement use. One open-label human study examining a multi-ingredient pre-workout containing higenamine reported modest increases in heart rate and fatty acid oxidation markers, but the presence of caffeine and other stimulants confounds attribution of any effect to higenamine alone. Overall, no randomized controlled trials isolating higenamine exist in humans, making evidence for performance enhancement, fat loss, or cardiotonic benefit in healthy adults preliminary at best.

Also Known As

Norcoclaurine1-(4-Hydroxybenzyl)-1,2,3,4-tetrahydroisoquinoline-6,7-diolDemethylcoclaurineHGBaifupian alkaloidLotus leaf alkaloid

Explore the Full Encyclopedia

Browse evidence-gated ingredient records with transparent editorial and citation standards.

Browse Ingredients
These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
From the Hermetica Research Desk

Research updates — and 25% off your first order

Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.

Educational content only — not medical advice.